• Login/Register
Fighting to preserve the benefits of the 340B program/
RWC-340B
  • Members
    • Meet RWC-340B
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Benefits Guide
    • Benefactor Application
  • Friends of RWC-340B
  • News & Events
  • Advocacy
  • Support 340B
  • 340B National Conferences
    • Fort Lauderdale, Florida
    • Chattanooga, Tennessee

Ryan White Clinics For 340B Access

Resources for Covered Entities in Response to Recent Actions Taken by Drug Manufacturers

  • Motion for Immediate Temporary Relief in RWC-340B v Azar (11/23/20)
  • Amended Complaint: RWC-340B v Azar (11/23/20)
  • Press Release: RWC-340B and 340B Grantee Plaintiffs File Lawsuit to Protect 340B Contract Pharmacy Program from Manufacturer Attacks That Are Undermining Patient Care and Public Health
    • COMPLAINT:  RWC-340B v Azar (Oct. 9, 2020)
  • CHART:  Overview of Recent Actions & Stakeholder Responses (Updated December 21, 2020)
  • Final Bipartisan Congressional Sign on Letter Regarding Recent Manufacturer Actions in the 340B Program (September 14, 2020)
  • Press Statement:  “Ryan White Clinics Call on Congress, HHS, & HRSA to Stop Drug Manufacturers from Undermining Our Use of the 340B Program to Care for People with HIV (August 27, 2020)
  • Letter to HHS Secretary Alex Azar: Manufacturer Actions Violating 340B Statute Requirements (September 14, 2020)
  • Press Release: Dozens of Attorneys General and Hundreds of Members of Congress Agree with RWC-340b:  Manufacturers’ Actions Against 340B Undermine the Safety Net (December 15, 2020)

RWC-340B Reduction in Resources White Paper

See resources on our recent study on the potential adverse impact of policies reducing resources to Ryan White clinics

  • White paper — Value of Ryan White Providers and Impacts Associated with Resource Reduction
  • Press release — RWC-340B press statement regarding the white paper and fact sheet
  • Fact sheet — How Ryan White Clinics use the 340B Drug Pricing Program
  • Funders — Special thank you to our funders who helped support this project.

I am 340B • The 340B Drug Discount Program allows safety net providers to provide life-saving drugs to people who might otherwise have no other source for medication. RWC-340B is committed to protecting and preserving the 340B Drug Discount Program.

Become a member of RWC-340B today!

What is 340B?

The federal 340B Drug Discount Program is a lifeline that allows safety net providers, including HIV/AIDS clinics receiving funding through the Ryan White program, to obtain prescription drugs at below-retail prices. The program was established with bipartisan support as part of the Veterans Health Care Act of 1992. With 340B savings, Ryan White clinics are able to stretch their grant funds, offer a wider range of services, and improve the quality of care persons living with HIV/AIDS receive.

With 340B savings, Ryan White clinics are able to:

  • Provide prescription drugs to needy patients at no or reduced cost

  • Assist patients with their insurance premiums, thus promoting medication adherence and continuous treatment

  • Provide medical services at little or no cost to needy patients

The 340B program is not funded by taxpayers, but rather is a discount that drug manufacturers must provide through an agreement with the government as a condition of Medicaid and Medicare covering their drugs.

340B Is Being Threatened

The 340B Program has come under intense scrutiny from the pharmaceutical industry and its allies, which have engaged in a coordinated campaign to distort the purpose and goals of the program. The program is simple: safety net providers purchase drugs at discounted prices, dispense or administer those drugs to their patients, and bill the responsible payer for those drugs.

Because the drugs cost less to obtain through the 340B program, the Ryan White clinic is able to do more with whatever income it receives – whether through reimbursement for services, grant funding, or private donations.

The program’s critics are attempting to undermine or even eliminate the program using a multitude of tactics, including:

  • Prohibiting the use of 340B drugs for insured patients
  • Eliminating or restricting the use of contract pharmacies to dispense 340B drugs to Ryan White clinic patients (many of which do not operate their own pharmacy)
  • Alleging that the program is being abused or used improperly

Worse, pharmacy benefit managers, insurers, and even some state Medicaid programs have begun to eye 340B Program savings as a mechanism to balance their own budgets.

Who Are We?

Ryan White Clinics for 340B Access (RWC-340B) is a national organization of HIV/AIDS health care clinics and service providers that receive funding under the Ryan White CARE Act, either through a primary grant or subgrant, and participate as covered entities in the federal 340B Drug Discount Program. The CARE Act provides funding for services primarily to poor and/or uninsured people with HIV/AIDS and the 340B program enables these providers to expand and support care.  In order to preserve access to the critically important 340B program, members of RWC-340B have pledged to work together to advocate for the interests of fellow 340B Ryan White providers.

Many Providers - One Voice

RWC-340B was organized in 2013 by a group of providers with one common goal – to preserve the benefits of the 340B program for themselves and for all private non-profit 340B program participants that provide primary care, case management, and other support services, with a particular focus on persons living with HIV/AIDS. While many of these are grantees under the Ryan White program, others might participate in the 340B program as federally qualified health centers or other provider types.  Most importantly, all rely on the 340B program to do more for their patients with less funding.

More Than Primary Care

All members of RWC-340B provide primary care to persons living with HIV/AIDS, but the 340B Program allows them to do so much more. Experts recognize that HIV/AIDS is not just a medical challenge, though medical providers can be an excellent gateway to the full spectrum of care and support persons living with HIV/AIDS need to succeed in their fight against the disease.  The 340B Program allows participants to stretch their resources to support the full HIV/AIDS Care Continuum, from diagnosis, to linkage to care, to medication adherence and viral suppression.

We Need You to Join Us!

RWC-340B is only as strong as its members. The political forces acting on the 340B Program include the pharmaceutical industry, physicians, hospitals, and others that are seasoned veterans in the halls of Congress. Our results are tangible and our stories are compelling, but we must strengthen our voice and demand attention lest we become another inadvertent casualty of political forces.

If you are:

  • A private non-profit provider of primary care with a focus on persons living with HIV/AIDS;
  • Participating or eligible to participate in the 340B program; and
  • Willing and able to stand up for your fellow providers and your patients

We need you to join us!  Please contact us using the form below to learn more about membership levels and dues structures.


    News and Events

    Read More

    ‘Nightmare scenario’: State cuts could impact HIV/AIDS patients across region

    The following article was originally posted in Drug Channels on WETM TV 18’s website, https://www.mytwintiers.com, on December 10, 2020.  Trillium Health is an

    share:
    12 Dec
    Read More

    Novo Nordisk and United Therapeutics Are the Latest Drug Manufacturers to Limit Access to 340B Prices at Contract Pharmacies

    On December 1, 2020, drug manufacturer Novo Nordisk Inc. announced that, effective January 1, 2021, it “will no longer facilitate ‘bill-to/ship-to’ distribution of 340B

    share:
    3 Dec
    Read More

    Press Release: RWC-340B and 340B Covered Entity Plaintiffs Ask Secretary of HHS to Immediately Enforce Covered Entities’ Rights Under 340B Statute

    Washington, D.C. – On November 23, 2020, Ryan White Clinics for 340B Access (RWC-340B) and five 340B providers filed a motion in the United States

    share:
    24 Nov
    Read More

    217 Congressional Representatives Send Letter to Secretary Azar Opposing the Kalderos Rebate Model

    Thanks to efforts by RWC-340B members and other covered entity advocates, 217 members of the House of Representatives signed a bipartisan letter to Health

    share:
    13 Nov
    Read More

    Novartis Takes a Less Restrictive Approach to 340B Pricing at Contract Pharmacies

    By letter dated October 30, 2020, Novartis is notifying covered entities that are federal grantees that they will continue to receive 340B discounts at

    share:
    2 Nov
    Read More

    RWC-340B/CV340B National Advocacy Webinar

    Please join us for the Community Voices for 340B and Ryan White Clinics for 340B Access’ National Advocacy Webinar

    share:
    29 Oct
        Load MoreVisit Blog    
    Top

    © 2016 Ryan White Clinics for 340B Access.  RWC-340B is a 501(c)(4) non-profit corporation.